ORKA
$71.93-2.63%
Oruka Therapeutics Inc.Stock · HealthcareRussell 2000 0.1%Nasdaq Composite 0.009%US Stock Market 0.007%Russell 3000 0.006%
Oruka Therapeutics Inc. total returns by year (including dividends)
As of market close, Oct 16, 2026
Oruka Therapeutics Inc. total returns by year (1998–2026)#
Calendar-year returns with each year's path and its dividend contribution (dividend return = total minus price return). Every year has a direct link you can bookmark or share.
| Year | Start price | End price | Path | Dividend | Total return |
|---|---|---|---|---|---|
| 2026YTD | $30.31 | $71.93 | 0.0% | +137.3% | |
| 2025 | $19.39 | $30.31 | 0.0% | +56.3% | |
| 2024 | $20.40 | $19.39 | 0.0% | -5.0% | |
| 2023 | $28.44 | $20.40 | 0.0% | -28.3% | |
| 2022 | $25.80 | $28.44 | 0.0% | +10.2% | |
| 2021 | $48.12 | $25.80 | 0.0% | -46.4% | |
| 2020 | $68.52 | $48.12 | 0.0% | -29.8% | |
| 2019 | $71.28 | $68.52 | 0.0% | -3.9% | |
| 2018 | $291.60 | $71.28 | 0.0% | -75.6% | |
| 2017 | $615.60 | $291.60 | 0.0% | -52.6% | |
| 2016 | $1,004.40 | $615.60 | 0.0% | -38.7% | |
| 2015 | $1,436.40 | $1,004.40 | 0.0% | -30.1% | |
| 2014 | $2,540.16 | $1,436.40 | 0.0% | -43.5% | |
| 2013 | $3,447.36 | $2,540.16 | 0.0% | -26.3% | |
| 2012 | $9,072.00 | $3,447.36 | 0.0% | -62.0% | |
| 2011 | $28,758.24 | $9,072.00 | 0.0% | -68.5% | |
| 2010 | $29,574.72 | $28,758.24 | 0.0% | -2.8% | |
| 2009 | $56,246.40 | $29,574.72 | 0.0% | -47.4% | |
| 2008 | $332,035.19 | $56,246.40 | 0.0% | -83.1% | |
| 2007 | $725,760.00 | $332,035.19 | 0.0% | -54.3% | |
| 2006 | $1,471,478.38 | $725,760.00 | 0.0% | -50.7% | |
| 2005 | $1,787,184.00 | $1,471,478.38 | 0.0% | -17.7% | |
| 2004 | $1,905,120.00 | $1,787,184.00 | 0.0% | -6.2% | |
| 2003 | $473,558.41 | $1,905,120.00 | 0.0% | +302.3% | |
| 2002 | $4,202,150.50 | $473,558.41 | 0.0% | -88.7% | |
| 2001 | $7,824,600.00 | $4,202,150.50 | 0.0% | -46.3% | |
| 2000 | $9,253,440.00 | $7,824,600.00 | 0.0% | -15.4% | |
| 1999 | $2,857,680.00 | $9,253,440.00 | 0.0% | +223.8% | |
| 1998 | $5,239,080.00 | $2,857,680.00 | 0.0% | -45.5% |
- Annualized
- -32.8%
- 1998–2026
- Average year
- -13.4%
- 28 full years
- Best year
- +302.3%
- 2003
- Worst year
- -88.7%
- 2002
- Positive years
- 4/28
- 14% up
Annualized (CAGR)
-32.8%
1998–2026
Average year
-13.4%
28 full years
Best year
+302.3%
2003
Worst year
-88.7%
2002
Positive years
4/28
14% up
Total return by period#
Annual
-300%-200%-100%0%100%200%300%
1998-45%'98
1999+224%
2000-15%'00
2001-46%
2002-89%'02
2003+302%
2004-6.2%'04
2005-18%
2006-51%'06
2007-54%
2008-83%'08
2009-47%
2010-2.8%'10
2011-68%
2012-62%'12
2013-26%
2014-43%'14
2015-30%
2016-39%'16
2017-53%
2018-76%'18
2019-3.9%
2020-30%'20
2021-46%
2022+10%'22
2023-28%
2024-5.0%'24
2025+56%
2026+137%'26
Methodology#
Total returns, dividends reinvested, measured on ORKA. Annualized return is the compound annual growth rate; the current year is year-to-date. Past performance does not predict future returns.
FAQ#
- What is Oruka Therapeutics Inc.'s average annual return?
- Since 1998, Oruka Therapeutics Inc. (ORKA) has returned about -32.8% a year (the compound annual growth rate) and an average calendar-year return of -13.4%.
- What were Oruka Therapeutics Inc.'s best and worst years?
- Over 1998–2026, the best year was 2003 (+302.3%) and the worst was 2002 (-88.7%).
- How often is Oruka Therapeutics Inc. up in a year?
- 4 of the 28 full years since 1998 were positive — about 14% of the time.
More on Oruka Therapeutics Inc.
Annual returns for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100